Further study has found that LinC00319 can directly bind to TATA box binding protein related factor 1 (TAF1) and further regulate HMGA2 to promote glioma cell proliferation, accelerate cell cycle, and inhibit glioma cell apoptosis, providing new ideas for molecular targeted therapy of glioma [108]. This evidence concerns the gene LINC00319 and central nervous system cancer.